Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Raw Materials (2023 - 2025)

Historic Raw Materials for Krystal Biotech (KRYS) over the last 3 years, with Q4 2025 value amounting to $15.9 million.

  • Krystal Biotech's Raw Materials rose 1685.61% to $15.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $15.9 million, marking a year-over-year increase of 1685.61%. This contributed to the annual value of $15.9 million for FY2025, which is 1685.61% up from last year.
  • As of Q4 2025, Krystal Biotech's Raw Materials stood at $15.9 million, which was up 1685.61% from $14.6 million recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's Raw Materials registered a high of $15.9 million during Q4 2025, and its lowest value of $3.2 million during Q4 2023.
  • Its 3-year average for Raw Materials is $10.6 million, with a median of $13.6 million in 2024.
  • Its Raw Materials has fluctuated over the past 5 years, first skyrocketed by 33243.5% in 2024, then surged by 1685.61% in 2025.
  • Krystal Biotech's Raw Materials (Quarter) stood at $3.2 million in 2023, then skyrocketed by 332.44% to $13.6 million in 2024, then increased by 16.86% to $15.9 million in 2025.
  • Its last three reported values are $15.9 million in Q4 2025, $14.6 million for Q3 2025, and $14.1 million during Q2 2025.